临床肝胆病杂志2024，Vol.40Issue(7)：1324-1327,4.DOI:10.12449/JCH240707
《原发性肝癌诊疗指南(2024年版)》解读
Interpretation of guidelines for the diagnosis and treatment of primary liver cancer(2024 edition)
李照 1朱继业1
作者信息
- 1. 北京大学人民医院肝胆外科,北京大学器官移植研究所,北京大学肝癌诊断治疗研究中心,北京 100044
- 折叠
摘要
Abstract
In June 2017,National Health Commission of the People's Republic of China released Guidelines for the diagnosis and treatment of primary liver cancer(2017 edition),which provided important recommendations for the diagnosis,staging,and treatment of liver cancer.Since then,high-level evidence in line with the principles of evidence-based medicine has been continuously obtained from the research on primary liver cancer in China and globally.Therefore,National Health Commission released Guidelines for the diagnosis and treatment of primary liver cancer(2024 edition).This article gives an interpretation of the updated key points in the guidelines,in order to better guide clinical practice.关键词
肝肿瘤/癌,肝细胞/肿瘤辅助疗法/精准医学/诊疗准则Key words
Liver Neoplasms/Carcinoma,Hepatocellular/Neoadjuvant Therapy/Precision Medicine/Practice Guideline引用本文复制引用
李照,朱继业..《原发性肝癌诊疗指南(2024年版)》解读[J].临床肝胆病杂志,2024,40(7):1324-1327,4.
